UNC School of Medicine researchers Meghan E. Rebuli, PhD, and Ilona Jaspers, PhD, are co-authors on a paper published Tuesday, Aug. 2, in The Lancet Respiratory Medicine, titled “Smoking and e-cigarette use: key variables in testing IgA-oriented intranasal vaccines.”
The UNC School of Medicine has been selected to participate in a new study to examine the comparative effectiveness of asthma treatments. The project will focus on which of two treatment types – inhaled steroids or specific antibiotics, alone or together – works best in different patients. The UNC site lead investigators are Michelle Hernandez, MD, professor in the UNC Department of Pediatrics, and Katrina Donahue, MD, MPH, professor and vice chair of research in the UNC Department of Family Medicine.
The Clinical Trials Unit in the UNC Children’s Research Institute is a site for a national study to assess the efficacy of Paxlovid, a pill to treat COVID in children under 18 at increased risk for severe illness.
With the FDA ordering Juul to stop selling their e-cigarette devices, UNC School of Medicine researchers led by Ilona Jaspers, PhD, published the first study to compare the respiratory immune health effects of different types of devices.
Matthew Vogt, MD, PhD, assistant professor of Pediatrics in the Division of Infectious Diseases and of Microbiology & Immunology, has been granted an R01 from the National Institute of Allergy and Infectious Diseases (NIAID).
The COVID-19 pandemic has demonstrated a critical need to establish a pre-emptive stockpile of tangible immunobiological countermeasures to accelerate the response to potential pandemic threats. To address this need we have established a pandemic response repository through microbial and immunological surveillance and epidemiology (PREMISE) initiative.
A study in Lancet Global Health led by UNC School of Medicine’s Peyton Thompson, MD, MSCR and Jonathan Parr, MD, MPH showed the feasibility and acceptance of hepatitis B virus testing, treatment, and vaccination programs in the Democratic Republic of the Congo.
Emily Ciccone, MD, MHS, will use the $25,000 award to differentiate viral and bacterial respiratory infections among malaria-negative children. The overall goal is to reduce unnecessary antibiotic use without compromising safety in an area where access to care is a real issue.
